Rated pharmaceutical companies Reported cash and debt, $US billions Source: Moody’s Investors Service, April 2010
Rated pharmaceutical companies Reported cash and debt, $US billions Source: Moody’s Investors Service, April 2010
Credit: 
3206DSN_ChainPharmacy5-fig1.jpg